CEO of Health Catalyst Inc (30-Year Financial, Insider Trades) Daniel D. Burton (insider trades) sold 200,570 shares of HCAT on 07/31/2020 at an average price of $35.37 a share. The total sale was $7.1 million.
Health Catalyst Inc has a market cap of $1.36 billion; its shares were traded at around $35.90 with and P/S ratio of 7.35. GuruFocus has detected 1 severe warning sign with Health Catalyst Inc. .
CEO Recent Trades:
- CEO Daniel D. Burton sold 200,570 shares of HCAT stock on 07/31/2020 at the average price of $35.37. The price of the stock has increased by 1.5% since.
- Warning! GuruFocus has detected 7 Warning Signs with HCAT. Click here to check it out.
- HCAT 30-Year Financial Data
- The intrinsic value of HCAT
- Peter Lynch Chart of HCAT
Directors and Officers Recent Trades:
- Director D Fraser Bullock sold 2,100 shares of HCAT stock on 07/28/2020 at the average price of $37.01. The price of the stock has decreased by 3% since.
- Director Anita Pramoda sold 30,000 shares of HCAT stock on 07/15/2020 at the average price of $36.2. The price of the stock has decreased by 0.83% since.
- General Counsel Daniel H. Orenstein sold 5,000 shares of HCAT stock on 07/15/2020 at the average price of $36.16. The price of the stock has decreased by 0.72% since.
For the complete insider trading history of HCAT, click here
.- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.